跳至主要内容
临床试验/NCT06191523
NCT06191523已完成不适用

The Effect of Melatonin as an Adjuvant Therapy for Preterm Neonates With Sepsis (Review of Malondialdehyde, Interleukin-6, Interleukin-8, Absolute Neutrophil Counts, and Sepsis Score)

Universitas Sebelas Maret1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2023年4月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
1
主要终点
Number of Participants with Treatment-Related Improvement of Sepsis Score Based on Gitto Scoring System

研究概览

简要总结

The goal of this clinical trial is to assess the effect of melatonin on MDA serum, IL-6, IL-8 levels, ANC, and sepsis score in preterm neonates with sepsis. The main question aim to answer :

• Does melatonin affect MDA serum, IL-6, IL-8 levels, ANC, and sepsis score in preterm neonates with sepsis?

The participants in the treatment group will receive a single dose of oral melatonin 20 mg, meanwhile those the control group will receive placebo.

The researchers will compare MDA serum, IL-6, IL-8 levels, ANC, and sepsis score before and after receiving melatonin, whether there are decreases of MDA serum, IL-6, IL-8 levels, ANC and increase of sepsis score

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
28 Weeks 至 36 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Newborns with gestational age of 28-36+6 weeks, birth weight according to gestational age, and diagnosis of sepsis based on HPS and PRS sepsis score criteria

排除标准

  • Major congenital anomalies of the gastrointestinal tract.
  • Continuous vomiting.
  • Newborns with hypoxic ischemic encephalopathy (HIE), intracranial hemorrhage, feeding intolerance, necrotizing enterocolitis (NEC) and hormonal disorders.
  • Septic shock.

研究组 & 干预措施

Control Group

Placebo Comparator

The control group will receive standard therapy and placebo.

干预措施: Control Group (Other)

Control Group

Placebo Comparator

The control group will receive standard therapy and placebo.

干预措施: Treatment Group (Drug)

Treatment Group

Experimental

The participants in the treatment group will receive standard therapy and a single dose of oral melatonin 20 mg

干预措施: Control Group (Other)

Treatment Group

Experimental

The participants in the treatment group will receive standard therapy and a single dose of oral melatonin 20 mg

干预措施: Treatment Group (Drug)

结局指标

主要结局

Number of Participants with Treatment-Related Improvement of Sepsis Score Based on Gitto Scoring System

时间窗: From enrollment to the end of treatment at 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dwi Hidayah

Doctoral Program

Universitas Sebelas Maret

研究点 (1)

Loading locations...

相似试验